Literature DB >> 16285711

Exploring the early steps of amyloid peptide aggregation by computers.

Normand Mousseau1, Philippe Derreumaux.   

Abstract

The assembly of normally soluble proteins into amyloid fibrils is a hallmark of neurodegenerative diseases. Because protein aggregation is very complex, involving a variety of oligomeric metastable intermediates, the detailed aggregation paths and structural characterization of the intermediates remain to be determined. Yet, there is strong evidence that these oligomers, which form early in the process of fibrillogenesis, are cytotoxic. In this paper, we review our current understanding of the underlying factors that promote the aggregation of peptides into amyloid fibrils. We focus here on the structural and dynamic aspects of the aggregation as observed in state-of-the-art computer simulations of amyloid-forming peptides with an emphasis on the activation-relaxation technique.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 16285711     DOI: 10.1021/ar050045a

Source DB:  PubMed          Journal:  Acc Chem Res        ISSN: 0001-4842            Impact factor:   22.384


  20 in total

1.  Modeling the Alzheimer Abeta17-42 fibril architecture: tight intermolecular sheet-sheet association and intramolecular hydrated cavities.

Authors:  Jie Zheng; Hyunbum Jang; Buyong Ma; Chung-Jun Tsai; Ruth Nussinov
Journal:  Biophys J       Date:  2007-08-03       Impact factor: 4.033

2.  Investigating the mechanism of peptide aggregation: insights from mixed monte carlo-molecular dynamics simulations.

Authors:  Massimiliano Meli; Giulia Morra; Giorgio Colombo
Journal:  Biophys J       Date:  2008-02-08       Impact factor: 4.033

Review 3.  Computational simulations of the early steps of protein aggregation.

Authors:  Guanghong Wei; Normand Mousseau; Philippe Derreumaux
Journal:  Prion       Date:  2007-01-05       Impact factor: 3.931

4.  Annular structures as intermediates in fibril formation of Alzheimer Abeta17-42.

Authors:  Jie Zheng; Hyunbum Jang; Buyong Ma; Ruth Nussinov
Journal:  J Phys Chem B       Date:  2008-05-06       Impact factor: 2.991

Review 5.  Amyloid β Protein and Alzheimer's Disease: When Computer Simulations Complement Experimental Studies.

Authors:  Jessica Nasica-Labouze; Phuong H Nguyen; Fabio Sterpone; Olivia Berthoumieu; Nicolae-Viorel Buchete; Sébastien Coté; Alfonso De Simone; Andrew J Doig; Peter Faller; Angel Garcia; Alessandro Laio; Mai Suan Li; Simone Melchionna; Normand Mousseau; Yuguang Mu; Anant Paravastu; Samuela Pasquali; David J Rosenman; Birgit Strodel; Bogdan Tarus; John H Viles; Tong Zhang; Chunyu Wang; Philippe Derreumaux
Journal:  Chem Rev       Date:  2015-03-19       Impact factor: 60.622

6.  The Effect of (-)-Epigallocatechin-3-Gallate on the Amyloid-β Secondary Structure.

Authors:  Atanu Acharya; Julia Stockmann; Léon Beyer; Till Rudack; Andreas Nabers; James C Gumbart; Klaus Gerwert; Victor S Batista
Journal:  Biophys J       Date:  2020-06-10       Impact factor: 4.033

7.  A Protocol for the Design of Protein and Peptide Nanostructure Self-Assemblies Exploiting Synthetic Amino Acids.

Authors:  Nurit Haspel; Jie Zheng; Carlos Aleman; David Zanuy; Ruth Nussinov
Journal:  Methods Mol Biol       Date:  2017

8.  Exploring the role of hydration and confinement in the aggregation of amyloidogenic peptides Aβ(16-22) and Sup35(7-13) in AOT reverse micelles.

Authors:  Anna Victoria Martinez; Edyta Małolepsza; Eva Rivera; Qing Lu; John E Straub
Journal:  J Chem Phys       Date:  2014-12-14       Impact factor: 3.488

9.  Molecular dynamics simulations of Alzheimer Abeta40 elongation and lateral association.

Authors:  Jie Zheng; Buyong Ma; Yung Chang; Ruth Nussinov
Journal:  Front Biosci       Date:  2008-05-01

10.  Polymorphism of Alzheimer's Abeta17-42 (p3) oligomers: the importance of the turn location and its conformation.

Authors:  Yifat Miller; Buyong Ma; Ruth Nussinov
Journal:  Biophys J       Date:  2009-08-19       Impact factor: 4.033

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.